Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)

Condition:   Obstructive Sleep Apnea Interventions:   Drug: Dosing 1: Atomoxetine;   Drug: Dosing 2-4: AD313 Sponsor:   Apnimed Recruiting

Source: ClinicalTrials.gov - November 1, 2021 Category: Research Source Type: clinical trials